News|Articles|June 1, 2002
- Pharmaceutical Technology-06-02-2002
- Volume 26
- Issue 6
Drug Shortages Reveal GMP Concerns
Author(s)Jill Wechsler
FDA cites manufacturing difficulties as a main contributing factor to recent drug shortages, which mainly involve injectibles and vaccines.
Advertisement
Articles in this issue
about 24 years ago
Excipient GMP Quality Standards: One is Enoughabout 24 years ago
The IPEC-Americas Excipient Master File Guideabout 24 years ago
Technology Advances Anticounterfeiting Optionsabout 24 years ago
Calibration of Lyophilization Pressure Gaugesabout 24 years ago
Outsourcing Outlookabout 24 years ago
Optimizing Cross-Organizational Team Performance and Managementabout 24 years ago
Screening for Counterfeit Drugs Using Near-Infrared Spectroscopyabout 24 years ago
Building on Tradition: Integrating the Links of ExpertiseAdvertisement
Related Content
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The FDA Moves to Modernize Drug Manufacturing Registration
2
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
3
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
4
Overcoming Raw-Material Variability Challenges for Autologous Adoptive Cell Therapies
5